One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Monitoring mental health care
doi : 10.1016/S2215-0366(22)00006-2
Volume 9, Issue 2, February 2022, Page 97
The true global disease burden of mental illness: still elusive
Daniel Vigo a, Laura Jones a, Rifat Atun b, Graham Thornicroft c
Opioid agonist treatment for self-harm and suicide prevention
Paul S Nestadt a b, Alison Athey b
Redesigning phase 3 and 4 trials to adopt shared decision making
Koen P Grootens a, Iris E Sommer b
Addressing fentanyl use disorder with fentanyl-assisted treatment
R Michael Krausz a, Jean N Westenberg b, Marc Vogel c d
Correction to Lancet Psychiatry 2021; 8: 1017
doi : 10.1016/S2215-0366(22)00001-3
Volume 9, Issue 2, February 2022, Page e7
Treatment adherence might be the key to online Exposure and Response Prevention for paediatric tics
doi : 10.1016/S2215-0366(21)00433-8
Volume 9, Issue 2, February 2022, Page 106
Treatment adherence might be the key to online Exposure and Response Prevention for paediatric tics – Authors' reply
doi : 10.1016/S2215-0366(21)00503-4
Volume 9, Issue 2, February 2022, Pages 106-107
China initiates depression screening in children and adolescents
doi : 10.1016/S2215-0366(21)00479-X
Volume 9, Issue 2, February 2022, Pages 107-108
Psychotropic medicines: increased appetite rather than weight gain
doi : 10.1016/S2215-0366(21)00500-9
Volume 9, Issue 2, February 2022, Page e8
Time to acknowledge the bias of some electroconvulsive therapy researchers and defenders
doi : 10.1016/S2215-0366(21)00506-X
Volume 9, Issue 2, February 2022, Page e9
Soumya Swaminathan: WHO Chief Scientist and passionate advocate of mental health
Tony Kirby
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Prof Celso Arango MD a, Prof Jan K Buitelaar MD b c, Prof Jörg M Fegert MD d, Valérie Olivier PharmD e, Pierre-François Pénélaud MD e, Ute Marx MD f, Damien Chimits MSc e, Prof Bruno Falissard MD g
Peer support for discharge from inpatient mental health care versus care as usual in England (ENRICH): a parallel, two-group, individually randomised controlled trial
doi : 10.1016/S2215-0366(21)00398-9
Volume 9, Issue 2, February 2022, Pages 125-136
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
doi : 10.1016/S2215-0366(21)00395-3
Volume 9, Issue 2, February 2022, Pages 137-150
Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study
Prianka Padmanathan MSc a e, Harriet Forbes PhD a, Maria Theresa Redaniel PhD a b, Prof David Gunnell FMedSci a c, Dan Lewer MSc d, Prof Paul Moran MD a b c, Ben Watson MD e, Prof Louisa Degenhardt PhD f, Prof Matthew Hickman PhD a c
The national suicide prevention strategy in India: context and considerations for urgent action
Lakshmi Vijayakumar PhD a b, Prof Prabha S Chandra MD c, Munirathinam Suresh Kumar MD d, Soumitra Pathare PhD e, Debanjan Banerjee MD c, Tanmoy Goswami MA f, Rakhi Dandona PhD g h
Public mental health: required actions to address implementation failure in the context of COVID-19
doi : 10.1016/S2215-0366(21)00199-1
Volume 9, Issue 2, February 2022, Pages 169-182
